The table below is a review of notable updates that occurred in February 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage ...

Adrenal cortical cancer (ACC) is very rare and also known as adrenocortical carcinoma. ACC starts in the outer layer of the adrenal glands, which are next to the kidneys. The adrenal glands are small ...

Therefore, this review aims to discuss the applications of PSMA-targeting radiopharmaceuticals in hepatic malignant tumors, focusing on hepatocellular carcinoma (HCC), to assess their value as a ...

HCC cells-derived EVs carrying proteins were found to inhibit ... tissue from in situ tumor-implanted mice showed a significant reduction in CD31-positive and CD34-positive endothelium (EC) in CLEC3B ...

Objective Hepatocellular carcinoma (HCC) is an aggressive malignancy with limited effective treatment options. An alternative strategy is to target cells, such as tumour-infiltrating macrophages, in ...

Background Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality. The combination of tremelimumab and durvalumab is now a standard treatment option for advanced HCC. Objective ...

Undisclosed Conflicts of Interest in Japanese Cancer Clinical Trials: A Cross-Sectional Study of Author-Pharmaceutical Industry Financial Relationships Global incidence of hepatocellular carcinoma ...

So the doctor says you have stage 0 breast cancer, and now you have lots of questions. What does that mean? Is it even really cancer? The truth is, doctors aren’t entirely sure either.

Search for other works by this author on: When the problem of carcinoma is approached from the metabolic aspect, the first question which arises is: how does the metabolism of growing tissue differ ...

What Is Renal Cell Carcinoma? It's the most common type of kidney cancer. Although it’s a serious disease, finding and treating it early makes it more likely that you’ll be cured. No matter ...